Discharge Medication Use Post-Operatively in GU Cancer Patients

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The main purpose of this research study is to determine the amount of opioids that are taken after discharge following a cystectomy, nephrectomy (partial or total), or prostatectomy surgeries via a 30-day post- discharge opioid use and disposal survey. We will also evaluate the impact of an opioid disposal education pamphlet on proper disposal of unused opioids.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Written informed consent and HIPAA authorization for release of personal health information.

• Age ≥ 18 years at the time of enrollment

• Scheduled to undergo surgical cystectomy, partial or total nephrectomy or prostatectomy for a cancer diagnosis.

• Ability to read and understand the English and/or Spanish language.

• As determined by the enrolling investigator, ability of the participant to understand and comply with study procedures for the entire length of the study.

Locations
United States
North Carolina
Levine Cancer Institute
RECRUITING
Charlotte
Contact Information
Primary
Margarita Dzhanumova
Margarita.Dzhanumova@advocatehealth.org
704-355-2000
Time Frame
Start Date: 2025-02-21
Estimated Completion Date: 2026-07
Participants
Target number of participants: 684
Treatments
Pre-Education Cohort
Post-Education Cohort
Related Therapeutic Areas
Sponsors
Collaborators: Atrium Health Levine Cancer Institute
Leads: Wake Forest University Health Sciences

This content was sourced from clinicaltrials.gov

Similar Clinical Trials